Cargando…

High Mobility Group Box 1 Mediates TMAO-Induced Endothelial Dysfunction

The intestinal microbe-derived metabolite trimethylamine N-oxide (TMAO) is implicated in the pathogenesis of cardiovascular diseases (CVDs). The molecular mechanisms of how TMAO induces atherosclerosis and CVDs’ progression are still unclear. In this regard, high-mobility group box protein 1 (HMGB1)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Gurinder Bir, Zhang, Yang, Boini, Krishna M., Koka, Saisudha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678463/ https://www.ncbi.nlm.nih.gov/pubmed/31336567 http://dx.doi.org/10.3390/ijms20143570

Ejemplares similares

Nicotine instigates podocyte injury via NLRP3 inflammasomes activation
por: Singh, Gurinder Bir, et al.
Publicado: (2019)

Obesity: An overview on its current perspectives and treatment options
por: Nammi, Srinivas, et al.
Publicado: (2004)

Instigation of NLRP3 inflammasome activation and glomerular injury in mice on the high fat diet: role of acid sphingomyelinase gene
por: Boini, Krishna M., et al.
Publicado: (2016)

Endothelial NLRP3 inflammasome activation and arterial neointima formation associated with acid sphingomyelinase during hypercholesterolemia
por: Koka, Saisudha, et al.
Publicado: (2017)

Inflammatory Mediators in Obesity
por: Kumar, Divya P., et al.
Publicado: (2019)

Glycyrrhizic Acid Inhibits High-Mobility Group Box-1 and Homocysteine-Induced Vascular Dysfunction
por: Gadanec, Laura Kate, et al.
Publicado: (2023)

High mobility group box 1: as a 'testament' mediator
por: Maruyama, I, et al.
Publicado: (2005)

TMAO: a potential mediator of clopidogrel resistance
por: Ma, Ruisong, et al.
Publicado: (2021)

Time-dependent specific molecular signatures of inflammation and remodelling are associated with trimethylamine-N-oxide (TMAO)-induced endothelial cell dysfunction
por: Shanmugham, Meyammai, et al.
Publicado: (2023)

The Proinflammatory Cytokine High-Mobility Group Box-1 Mediates Retinal Neuropathy Induced by Diabetes
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2014)

Modulation of Endothelial Function by TMAO, a Gut Microbiota-Derived Metabolite
por: Querio, Giulia, et al.
Publicado: (2023)

Antagonism of Cerebral High Mobility Group Box 1 Ameliorates Dendritic Cell Dysfunction in Sepsis
por: Ren, Chao, et al.
Publicado: (2021)

The potential mechanism of extracellular high mobility group box-1 protein mediated p53 expression in immune dysfunction of T lymphocytes
por: Luan, Ying-Yi, et al.
Publicado: (2017)

High-mobility group box 1: role in ARDS
por: Ishizaka, A, et al.
Publicado: (2005)

High‐Mobility Group Box‐1 and Liver Disease
por: Gaskell, Harriet, et al.
Publicado: (2018)

High mobility group box 1 in diabetic nephropathy
por: Shi, Haitao, et al.
Publicado: (2017)

High Mobility Group Box 1 in Human Cancer
por: Rapoport, Bernardo L., et al.
Publicado: (2020)

Histamine induced high mobility group box-1 release from vascular endothelial cells through H(1) receptor
por: Gao, Shangze, et al.
Publicado: (2022)

Epigallocatechin Gallate (EGCG) Improves Anti-Angiogenic State, Cell Viability, and Hypoxia-Induced Endothelial Dysfunction by Downregulating High Mobility Group Box 1 (HMGB1) in Preeclampsia
por: Zhong, Min, et al.
Publicado: (2020)

High-Mobility Group Box 1 Induces Calcineurin-Mediated Cell Hypertrophy in Neonatal Rat Ventricular Myocytes
por: Su, Fei-fei, et al.
Publicado: (2012)

Toll-Like Receptor 4 Mediates Acute Lung Injury Induced by High Mobility Group Box-1
por: Deng, Yuxiao, et al.
Publicado: (2013)

Extracellular high‐mobility group box 1 mediates pressure overload‐induced cardiac hypertrophy and heart failure
por: Zhang, Lei, et al.
Publicado: (2015)

Histidine-Rich Glycoprotein Inhibits High-Mobility Group Box-1-Mediated Pathways in Vascular Endothelial Cells through CLEC-1A
por: Gao, Shangze, et al.
Publicado: (2020)

The Role of High Mobility Group Box 1 in Innate Immunity
por: Lee, Shin-Ae, et al.
Publicado: (2014)

High Mobility Group Box Protein-1 in Wound Repair
por: Ranzato, Elia, et al.
Publicado: (2012)

High-Mobility Group Box 1 in Dry Eye Inflammation
por: Lema, Carolina, et al.
Publicado: (2018)

The Role of High Mobility Group Box 1 in Ischemic Stroke
por: Ye, Yingze, et al.
Publicado: (2019)

Role of High-Mobility Group Box-1 in Liver Pathogenesis
por: Khambu, Bilon, et al.
Publicado: (2019)

High Mobility Group Box 1 Protein in Cerebral Thromboemboli
por: Essig, Fabian, et al.
Publicado: (2021)

Urinary and serum levels of high mobility group box 1
por: Nakamura, Toshihiko, et al.
Publicado: (2023)

Role of high-mobility group box 1 in patients with acute obstructive suppurative cholangitis-induced sepsis
por: Singh, Akanand, et al.
Publicado: (2015)

Blockade of high-mobility group box 1 attenuates intestinal mucosal barrier dysfunction in experimental acute pancreatitis
por: Chen, Xia, et al.
Publicado: (2017)

Adsorption of the Inflammatory Mediator High-Mobility Group Box 1 by Polymers with Different Charge and Porosity
por: Tripisciano, Carla, et al.
Publicado: (2014)

Endothelial Dysfunction and Diabetes: Effects on Angiogenesis, Vascular Remodeling, and Wound Healing
por: Kolluru, Gopi Krishna, et al.
Publicado: (2012)

Role of high-mobility group box 1 in methamphetamine-induced activation and migration of astrocytes
por: Zhang, Yuan, et al.
Publicado: (2015)

High-Mobility Group Box 1-Induced Complement Activation Causes Sterile Inflammation
por: Kim, Sook Young, et al.
Publicado: (2018)

Ethyl pyruvate attenuates ventilation‐induced diaphragm dysfunction through high‐mobility group box‐1 in a murine endotoxaemia model
por: Liu, Yung‐Yang, et al.
Publicado: (2019)

High-Mobility Group Box-1 Induces Decreased Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in the Diabetic Retina
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2013)

Vagal modulation of high mobility group box-1 protein mediates electroacupuncture-induced cardioprotection in ischemia-reperfusion injury
por: Zhang, Juan, et al.
Publicado: (2015)

Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota
por: Chen, Ming-liang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_blbtcdmce53bf66uh8v1u4g27t